TET2 and acute myeloid leukemia: The detected SNVs included: TET2:chr4:106155751:G/A, TET2:chr4:106158216:G/A, EZH2:chr7:148504716:AG/A, EZH2:chr7:148506064:A/G, EZH2:chr7:148543525:A/G, CBL:chr11:119148573:G/T, MYH11:chr16:15817995:G/A, MYH11:chr16:15838940:G/C, MYH11:chr16:15850204:A/G, and MYH11:chr16:15853596:C/G, which are not pathological variants associated with AML and are not indicative of residual disease.